Serological Study of the Exposure of Personnel to COVID-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

957 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-06-08

Study Completion Date

2020-07-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A seroconversion test for SARS-Cov-2 will be offered to all the employees of a care institution, which has treated 240 patients hospitalized for COVID disease between 28/02 and 30/04/2020. The seroconversion test will be with a questionnaire to determine:

* whether the subject has shown signs of infection in the last 3 recent months
* if the subject has been in contact with COVID-diagnosed subjects (RT-PCR diagnosis or scanner) outside of the activity or within the professional activity (patient or colleague)
* Working conditions during the period
* The level of knowledge and respect of the barrier measures practices.
* Respect for distance during meals professional. Overall seroprevalence and stratified seroprevalence by care and administrative areas will be determined.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur

NCT04369066

Volunteers From the Institute Curie and Institute Pasteur Staff Who Are Not Showing Active SARS-CoV-2 Infection

COMPLETED NA

Study of the Analytical Performance of Different Salivary Self-collection Methods for the Detection of COVID-19

NCT04550390

SARS-CoV Infection

COMPLETED

COVID 19-Caregivers IGg Seroconversion

NCT04353323

Infection, COVID-19

UNKNOWN

Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID-19.

NCT04322279

Coronavirus

TERMINATED

Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP

NCT04442087

SARS-CoV2

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sars-CoV2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CoVID exposure

Group Type OTHER

Sars-Cov-2 serology

Intervention Type DIAGNOSTIC_TEST

Measurement of overall seroprevalence of SARS-Cov-2 in an hospital staff

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sars-Cov-2 serology

Measurement of overall seroprevalence of SARS-Cov-2 in an hospital staff

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

serology

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject who worked at Saint Joseph Saint Luke's Hospital during the epidemic wave (male or female).

* Free and informed consent
* Social security affiliation